Luxsol™
Prevention and Treatment of Covid-19 and Influenza
Pre-clinicalActive
Key Facts
Indication
Prevention and Treatment of Covid-19 and Influenza
Phase
Pre-clinical
Status
Active
Company
About 3V Medical Research Group
3V Medical Research Group is a private, pre-revenue biotech focused on drug delivery for high-prevalence conditions. Its pipeline includes two pre-clinical assets targeting major viral infections and significant pain indications. The company emphasizes a development strategy built on safety, simple active ingredients, and established delivery methods, supported by a portfolio of pending and approved patents and trademarks. Its success hinges on advancing these candidates through clinical validation and into markets with substantial unmet needs.
View full company profile